Library — CHDR

Search

Filter

Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans.

Klumpers LE, Roy C, Ferron G, Turpault S, Poitiers F, Pinquier JL, van Hasselt JG, Zuurman L, Erwich FA, van Gerven JM

British journal of clinical pharmacology, 2013 Jun; 76(1):65-77

View publication
Dopamine-dependent architecture of cortico-subcortical network connectivity.

Cole DM, Oei NY, Soeter RP, Both S, van Gerven JM, Rombouts SA, Beckmann CF

Cerebral cortex (New York, N.Y. : 1991), 2013 Jun; 23(7):1509-16

View publication
Tolerability, pharmacokinetics, and pharmacodynamics of single-dose almorexant, an orexin receptor antagonist, in healthy elderly subjects.

Hoever P, Hay J, Rad M, Cavallaro M, van Gerven JM, Dingemanse J

Journal of clinical psychopharmacology, 2013 May; 33(3):363-70

View publication
Early stage development of the glycine-1 re-uptake inhibitor SCH 900435: central nervous system effects compared with placebo in healthy men.

Liem-Moolenaar M, Peeters P, Kamerling IM, Hogg C, Holder G, Kleijn HJ, Spaans E, Udo De Haes J, de Kam ML, Franson KL, Cohen AF, van Gerven JM

British journal of clinical pharmacology, 2013 May; 75(6):1455-67

View publication
Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.

Heuberger JA, Cohen Tervaert JM, Schepers FM, Vliegenthart AD, Rotmans JI, Daniels JM, Burggraaf J, Cohen AF

British journal of clinical pharmacology, 2013 May; 75(6):1406-21

View publication
Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.

te Beek ET, Hay JL, Bullman JN, Burgess C, Nahon KJ, Klaassen ES, Gray FA, van Gerven JM

British journal of clinical pharmacology, 2013 Apr; 75(5):1328-39

View publication
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.

Kuepper R, Ceccarini J, Lataster J, van Os J, van Kroonenburgh M, van Gerven JM, Marcelis M, Van Laere K, Henquet C

PloS one, 2013 Apr; 8(7):e70378

View publication
Evaluation of a bedside device to assess the activated partial thromboplastin time for heparin monitoring in infants.

Klein RH, van der Vorst MM, de Wilde RB, Hogenbirk K, de Kam ML, Burggraaf J

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013 Mar; 24(3):327-31

View publication
Determination of methylphenidate in plasma and saliva by liquid chromatography/tandem mass spectrometry.

Seçilir A, Schrier L, Bijleveld YA, Toersche JH, Jorjani S, Burggraaf J, van Gerven J, Mathôt RA

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013 Mar

View publication

«
1
2
...
55
56
57
58
59
60
61
...
98
99
»